English
A A A
EN
Bereichsnavigation

Vorherige
Managers' Transactions & Directors' Dealings | 18.06.2013

DGAP-Stimmrechte: RHÖN-KLINIKUM AG (english)

DGAP-Stimmrechte: RHÖN-KLINIKUM AG (english)

RHÖN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG

[the German Securities Trading Act] with the objective of Europe-wide

distribution



RHÖN-KLINIKUM AG



18.06.2013 15:45



Dissemination of a Voting Rights Announcement, transmitted by

DGAP - a company of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------





Notification according to section 26 para. 1 WpHG



Credit Suisse Group AG, Zürich, Switzerland, Credit Suisse AG, Zürich,

Switzerland, Credit Suisse Investments (UK), London, UK, Credit Suisse

Investment Holdings (UK), London, UK, and Credit Suisse Securities (Europe)

Limited, London, UK notified us on 18 June 2013 pursuant to section 25a

para. 1 WpHG of the following:



1) On 13 June 2013, Credit Suisse Group AG fell below the threshold of 5%

of the voting rights of RHÖN-KLINIKUM AG, Schlossplatz 1, 97616 Bad

Neustadt a. d. Saale, Germany. On that date, Credit Suisse Group AG held

3.70% of the voting rights in RHÖN-KLINIKUM AG (equals 5,114,410 voting

rights).



From these voting rights a proportion of 0.19% (equals 267,402 voting

rights) is based on voting rights pursuant to sections 21, 22 WpHG.



In addition, a proportion of 2.08% (equals 2,875,000 voting rights) is

based on (financial/other) instruments pursuant to section 25 WpHG. From

the voting rights based on instruments pursuant to section 25 WpHG a

proportion of 2.08% (equals 2,875,000 voting rights) is held indirectly.



In addition, a proportion of 1.43% (equals 1,972,008 voting rights) is

based on (financial/other) instruments pursuant to section 25a WpHG. From

the voting rights based on instruments pursuant to section 25a WpHG a

proportion of 1.43% (equals 1,972,008 voting rights) is held indirectly

(chain of controlled undertakings: Credit Suisse AG, Credit Suisse

Investments (UK), Credit Suisse Investment Holdings (UK), Credit Suisse

Securities (Europe) Limited).



The (financial/other) instruments pursuant to section 25a WpHG are

described as follows:



- Long Equity Swap, cash settlement (expiration date 18.06.2013)



- Long Equity Swap, cash settlement (expiration date 23.12.2013)



- Long Equity Swap, cash settlement (expiration date 06.01.2014)



- Long Equity Swap, cash settlement (expiration date 10.02.2014)



- Long Equity Swap, cash settlement (expiration date 02.05.2014)



- Long Equity Swap, cash settlement (expiration date 12.05.2014)



- Long Equity Swap, cash settlement (expiration date 05.08.2014)



- Long Equity Swap, cash settlement (expiration date 08.09.2014)



- Long Equity Swap, cash settlement (expiration date 03.11.2014)



- Long Equity Swap, cash settlement (expiration date 07.04.2015)



- Long Equity Swap, cash settlement (expiration date 27.04.2015)



- Long Equity Swap, cash settlement (expiration date 02.10.2017)







2) On 13 June 2013, Credit Suisse AG fell below the threshold of 5% of the

voting rights of RHÖN-KLINIKUM AG, Schlossplatz 1, 97616 Bad Neustadt a. d.

Saale, Germany. On that date Credit Suisse AG held 3.70% of the voting

rights in RHÖN-KLINIKUM AG (equals 5,114,410 voting rights).



From these voting rights a proportion of 0.19% (equals 267,402 voting

rights) is based on voting rights pursuant to sections 21, 22 WpHG.



In addition, a proportion of 2.08% (equals 2,875,000 voting rights) is

based on (financial/other) instruments pursuant to section 25 WpHG. From

the voting rights based on instruments pursuant to section 25 WpHG a

proportion of 2.08% (equals 2,875,000 voting rights) is held indirectly.



In addition, a proportion of 1.43% (equals 1,972,008 voting rights) is

based on (financial/other) instruments pursuant to section 25a WpHG. From

the voting rights based on instruments pursuant to section 25a WpHG a

proportion of 1.43% (equals 1,972,008 voting rights) is held indirectly

(chain of controlled undertakings: Credit Suisse Investments (UK), Credit

Suisse Investment Holdings (UK), Credit Suisse Securities (Europe)

Limited).



The (financial/other) instruments pursuant to section 25a WpHG are

described as follows:



- Long Equity Swap, cash settlement (expiration date 18.06.2013)



- Long Equity Swap, cash settlement (expiration date 23.12.2013)



- Long Equity Swap, cash settlement (expiration date 06.01.2014)



- Long Equity Swap, cash settlement (expiration date 10.02.2014)



- Long Equity Swap, cash settlement (expiration date 02.05.2014)



- Long Equity Swap, cash settlement (expiration date 12.05.2014)



- Long Equity Swap, cash settlement (expiration date 05.08.2014)



- Long Equity Swap, cash settlement (expiration date 08.09.2014)



- Long Equity Swap, cash settlement (expiration date 03.11.2014)



- Long Equity Swap, cash settlement (expiration date 07.04.2015)



- Long Equity Swap, cash settlement (expiration date 27.04.2015)



- Long Equity Swap, cash settlement (expiration date 02.10.2017)







3) On 13 June 2013, Credit Suisse Investments (UK) fell below the threshold

of 5% of the voting rights of RHÖN-KLINIKUM AG, Schlossplatz 1, 97616 Bad

Neustadt a. d. Saale, Germany. On that date Credit Suisse Investments (UK)

held 3.51% of the voting rights in RHÖN-KLINIKUM AG (equals 4,874,008

voting rights).



From these voting rights a proportion of 0% (equals 0 voting rights) is

based on voting rights pursuant to sections 21, 22 WpHG.



In addition, a proportion of 2.08% (equals 2,875,000 voting rights) is

based on (financial/other) instruments pursuant to section 25 WpHG. From

the voting rights based on instruments pursuant to section 25 WpHG a

proportion of 2.08% (equals 2,875,000 voting rights) is held indirectly.



In addition, a proportion of 1.43% (equals 1,972,008 voting rights) is

based on (financial/other) instruments pursuant to section 25a WpHG. From

the voting rights based on instruments pursuant to section 25a WpHG a

proportion of 1.43% (equals 1,972,008 voting rights) is held indirectly

(chain of controlled undertakings: Credit Suisse Investment Holdings (UK),

Credit Suisse Securities (Europe) Limited).



The (financial/other) instruments pursuant to section 25a WpHG are

described as follows:



- Long Equity Swap, cash settlement (expiration date 18.06.2013)



- Long Equity Swap, cash settlement (expiration date 23.12.2013)



- Long Equity Swap, cash settlement (expiration date 06.01.2014)



- Long Equity Swap, cash settlement (expiration date 10.02.2014)



- Long Equity Swap, cash settlement (expiration date 02.05.2014)



- Long Equity Swap, cash settlement (expiration date 12.05.2014)



- Long Equity Swap, cash settlement (expiration date 05.08.2014)



- Long Equity Swap, cash settlement (expiration date 08.09.2014)



- Long Equity Swap, cash settlement (expiration date 03.11.2014)



- Long Equity Swap, cash settlement (expiration date 07.04.2015)



- Long Equity Swap, cash settlement (expiration date 27.04.2015)



- Long Equity Swap, cash settlement (expiration date 02.10.2017)







4) On 13 June 2013, Credit Suisse Investment Holdings (UK) fell below the

threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Schlossplatz 1,

97616 Bad Neustadt a. d. Saale, Germany. On that date Credit Suisse

Investment Holdings (UK) held 3,51% of the voting rights in RHÖN-KLINIKUM

AG (equals 4,847,008 voting rights).



From these voting rights a proportion of 0% (equals 0 voting rights) is

based on voting rights pursuant to sections 21, 22 WpHG.



In addition, a proportion of 2.08% (equals 2,875,000 voting rights) is

based on (financial/other) instruments pursuant to section 25 WpHG. From

the voting rights based on instruments pursuant to section 25 WpHG a

proportion of 2.08% (equals 2,875,000 voting rights) is held indirectly.



In addition, a proportion of 1.43% (equals 1,972,008 voting rights) is

based on (financial/other) instruments pursuant to section 25a WpHG. From

the voting rights based on instruments pursuant to section 25a WpHG a

proportion of 1.43% (equals 1.972,008 voting rights) is held indirectly

(chain of controlled undertakings: Credit Suisse Securities (Europe)

Limited).



The (financial/other) instruments pursuant to section 25a WpHG are

described as follows:



- Long Equity Swap, cash settlement (expiration date 18.06.2013)



- Long Equity Swap, cash settlement (expiration date 23.12.2013)



- Long Equity Swap, cash settlement (expiration date 06.01.2014)



- Long Equity Swap, cash settlement (expiration date 10.02.2014)



- Long Equity Swap, cash settlement (expiration date 02.05.2014)



- Long Equity Swap, cash settlement (expiration date 12.05.2014)



- Long Equity Swap, cash settlement (expiration date 05.08.2014)



- Long Equity Swap, cash settlement (expiration date 08.09.2014)



- Long Equity Swap, cash settlement (expiration date 03.11.2014)



- Long Equity Swap, cash settlement (expiration date 07.04.2015)



- Long Equity Swap, cash settlement (expiration date 27.04.2015)



- Long Equity Swap, cash settlement (expiration date 02.10.2017)







5) On 13 June 2013, Credit Suisse Securities (Europe) Limited fell below

the threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Schlossplatz

1, 97616 Bad Neustadt a. d. Saale, Germany. On that date Credit Suisse

Securities (Europe) Limited held 3.51% of the voting rights in

RHÖN-KLINIKUM AG (equals 4,847,008 voting rights).



From these voting rights a proportion of 0% (equals 0 voting rights) is

based on voting rights pursuant to sections 21, 22 WpHG. In addition, a

proportion of 2.08% (equals 2,875,000 voting rights) is based on

(financial/other) instruments pursuant to section 25 WpHG. In addition, a

proportion of 1.43% (equals 1.972,008 voting rights) is based on

(financial/other) instruments pursuant to section 25a WpHG.



The (financial/other) instruments pursuant to section 25a WpHG are

described as follows:



- Long Equity Swap, cash settlement (expiration date 18.06.2013)



- Long Equity Swap, cash settlement (expiration date 23.12.2013)



- Long Equity Swap, cash settlement (expiration date 06.01.2014)



- Long Equity Swap, cash settlement (expiration date 10.02.2014)



- Long Equity Swap, cash settlement (expiration date 02.05.2014)



- Long Equity Swap, cash settlement (expiration date 12.05.2014)



- Long Equity Swap, cash settlement (expiration date 05.08.2014)



- Long Equity Swap, cash settlement (expiration date 08.09.2014)



- Long Equity Swap, cash settlement (expiration date 03.11.2014)



- Long Equity Swap, cash settlement (expiration date 07.04.2015)



- Long Equity Swap, cash settlement (expiration date 27.04.2015)



- Long Equity Swap, cash settlement (expiration date 02.10.2017)







Bad Neustadt a.d. Saale, 18 June 2013



The Board of Management



___________________________________________________________________________



Dr. Kai G. Klinger

Head of Investor Relations

RHÖN-KLINIKUM AG

Schlossplatz 1

97616 Bad Neustadt a. d. Saale

Phone: +49 9771 65 - 1318

Fax: +49 9771 99 - 1736







18.06.2013 DGAP's Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de



---------------------------------------------------------------------------



Language: English

Company: RHÖN-KLINIKUM AG

Schlossplatz 1

97616 Bad Neustadt a.d.Saale

Germany

Internet: www.rhoen-klinikum-ag.com



End of Announcement DGAP News-Service



---------------------------------------------------------------------------









Weitere Informationen: www.dpa-AFX.de

Experten finden

Unsere Kliniken

Kontakt

Tel: +49 9771 65-0

Cookies ändern